Equality and Diversity Champions celebrated at the Wellcome Genome Campus
Winners of the Best Practice Awards are announced for International Women’s Day
The Wellcome Genome Campus is celebrating International Women’s Day with its annual awards for Best Practice for Supporting Equality and Diversity in Science.
The Campus is fully committed to supporting the development of the careers of women and under-represented groups, and the awards recognise this. Staff at the Wellcome Genome Campus nominated 26 colleagues for their efforts to advance equality, diversity and inclusion, to positively impact working life on the Campus.
Amongst a highly competitive field, there were three joint winners: Lindsey Crosswell from EMBL’s European Bioinformatics Institute (EMBL-EBI), Ireena Dutta from Connecting Science, and Hannah Hurst from ELIXIR.
Lindsey Crosswell is the Head of External Relations at EMBL-EBI. She has been recognised for her outstanding contribution to developing the Equality in Science programme on Campus over several years. As a result of her influence, the first specialist Gender Project Officer was appointed at EMBL-EBI in 2016, a role that has since expanded to include all aspects of Equality and Diversity.
“I’m very pleased to have been recognised by colleagues, through the Best Practice Award, for the small part I play in promoting equality and diversity. There is still plenty to be done. Change doesn’t happen overnight; it will be the result of lots of small initiatives sustained and built upon over time.”
Lindsey Crosswell, Head of External Relations, EMBL-EBI
Ireena Dutta is Head of Strategy at Wellcome Genome Campus Connecting Science, which connects researchers, health professionals and the wider public, creating opportunities and spaces to explore genomic science and its impact on people. Ireena was nominated for her passion for equality and diversity in science, and her encouragement of women returning from or going on maternity leave. Her absolute resolve is that having a family should in no way impact a woman’s career and she is an outstanding supporter of career development.
“I’m surprised and very happy to have won this award, but I feel this isn’t really about me. It feels more of a wider acknowledgement of the barriers and challenges that certain groups including women can face in their careers. It is great to feel I’ve made a positive contribution towards addressing those challenges by advocating for colleagues and supporting flexible working policies and practices.”
Dr Ireena Dutta, Head of Strategy at Connecting Science
Hannah Hurst is Project Manager at ELIXIR, the pan-European infrastructure for sharing biological data. She received multiple nominations from team members and colleagues, for volunteering to take responsibility for equality and diversity across the ELIXIR Hub. Hannah worked on producing an Equal Opportunities Strategy document for use across ELIXIR’s international Nodes and successfully piloted the ELIXIR Code of Conduct at several events.
“It’s fantastic to have been awarded this. Not only a huge honour to me personally, but to ELIXIR itself as equality and diversity strengthens ELIXIR as an organisation. We have people from all walks of life and it is important to make sure everyone feels welcome and included. Obviously there is still work to do in many aspects of diversity, not just gender, but it’s a great honour that this huge team effort has been recognised.”
Hannah Hurst, Project Manager at ELIXIR
The Campus-wide Equality in Science Programme aims to raise awareness about issues facing women and marginalised groups in science, provides development opportunities, generates discussion and drives policy and practice change.
A further four people received Special Commendations: Sean Laidlaw, Bioinformatician at the Wellcome Sanger Institute, for helping to lead and grow the LGBT+ Network on campus; Hannah Currant and Sampurna Mukherjee, PhD students at EMBL-EBI, for running group mentoring events for the benefit of staff on campus; and Harriet Craven, Senior Software Developer at the Wellcome Sanger Institute for her outreach work in encouraging girls to get involved in STEM and computer science.
“Science benefits from the diversity of the people working on it so equality and inclusion is something we actively promote. Equality and inclusion are a marathon and not a race; changes across the organisation will take time but we’re prepared to put in the work because we believe diversity benefits everyone.”
Dr Ewan Birney, Director of EMBL-EBI
“We have celebrated International Women’s Day every year for the last several years. These awards provide us with a time to reflect on how our organisations are thinking about equality and diversity, and the improvements we are making at the Wellcome Genome Campus. It’s very satisfying to see that we are collectively becoming more conscious and aware of the issues. I think there has been extraordinary progress and it is great to be able to celebrate it.”
Professor Mike Stratton, Director of the Wellcome Sanger Institute
The full list of nominees is:
Annabel Smith, Carla Jones, Catriona Clarke, Cindy Smidt, Cordelia Langford, Georgia Hingston, Hannah Currant, Hannah Hurst, Harriet Craven, Helen Parkinson, Ireena Dutta, Jackie MacArthur, Laura Fachal, Lindsey Crosswell, Maria Herrero-Zazo, Maya Ghoussaini, Michelle Craske, Nicole Soranzo, Niki Web, Patricia Jaaks, Roser Vento, Sampurna Mukherjee, Sarah Morgan, Sean Laidlaw, Steven Newhouse, Susan Wallace and Vika Lebedeva-Baxter.
Wellcome Genome Campus Connecting Science’s mission is to enable everyone to explore genomic science and its impact on research, health and society.
We connect researchers, health professionals and the wider public, creating opportunities and spaces to explore genomic science and its impact on people. Connecting Science inspires new thinking, sparks conversation, supports learning and measures attitudes, drawing on the ground-breaking research taking place on the Wellcome Genome Campus. wellcomegenomecampus.org/connectingscience
The European Bioinformatics Institute (EMBL-EBI) is a global leader in the storage, analysis and dissemination of large biological datasets. We help scientists realise the potential of ‘big data’ by enhancing their ability to exploit complex information to make discoveries that benefit humankind. We are at the forefront of computational biology research, with work spanning sequence analysis methods, multi-dimensional statistical analysis and data-driven biological discovery, from plant biology to mammalian development and disease. We are part of EMBL and are located on the Wellcome Genome Campus, one of the world’s largest concentrations of scientific and technical expertise in genomics. www.ebi.ac.uk
The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog
Wellcome exists to improve health by helping great ideas to thrive. We support researchers, we take on big health challenges, we campaign for better science, and we help everyone get involved with science and health research. We are a politically and financially independent foundation. https://wellcome.org/
Related blog posts
30 May 2019
Equality and Diversity – not just about fairness
We've come a long way, but the journey isn't finished yet...
10 Jan 2020
2020 vision: supporting the people behind our science
Read about our ongoing and upcoming work to ensure that all our staff and students from all backgrounds can thrive
12 Apr 2021
New genetic drug target for treatment resistant colorectal cancer
Researchers have identified a new potential drug target for treating some types of advanced colorectal cancers.
7 Apr 2021
‘Patchwork’ tumours prevalent across multiple cancer types
Scientists have confirmed that tumour evolution is driven by changes that benefit the cancer, and these lead to a wide range ...